Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Stepping Stone or a Headache? 2023 MIPS Value Pathway Survey Findings

Allison Plitman  |  July 10, 2024

“Although the issues raised are outside of our direct control, we are using every channel we have available to advocate for these issues with the CMS, such as including this feedback in our upcoming comments in response to CMS’ recently released 2025 Proposed Rule,” says Ms. Johansson. “We recognize the important role we play in serving as a strong voice for our practices when it comes to the federal government’s payment programs.”

Finding 5: 89% Plan to Report the 2024 MVP Through RISE

When asked about 2024 reporting plans, 89% stated they intend to submit for the MVP. The other 11% indicated they were unsure of their reporting plans for 2024. Additionally, 44% of survey respondents intend to only report for the 2024 MVP and not traditional MIPS.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“My practice plans to only report for the 2024 MVP and not for traditional MIPS,” explains Ms. Rendon. “Because it is the way CMS is heading, we might as well get ahead and know what it is all about.”

“We at RISE find those numbers really encouraging,” Ms. Johansson says. “Although the first year of anything inherently means paving the way to a certain extent, we are glad providers are finding the MVP we helped CMS build meets their needs so far and look forward to supporting the MVP again for 2024 QPP reporting.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Conclusion

Although the inaugural year for the MVP had its ups and downs, the survey data indicate providers who reported through RISE had an overall positive experience. They also identified clear pathways for improvement.

“The survey data are instrumental in guiding RISE as we support our users through QPP reporting,” Ms. Johansson says. “Not only will we use it to directly address challenges from this year’s reporting, but we are better able to reflect the opinions of our users to CMS and the federal government at large.”

Want to learn more about the 2023 MVP reporting experience? Email the RISE team at [email protected].


Allison Plitman, MPA, is the senior communications specialist for the ACR’s RISE registry.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:MIPSQuality Payment Program (QPP)

Related Articles

    2024 Proposed Rule for the Quality Payment Program Released

    August 17, 2023

    See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

    Evolution of Medicare’s Merit-Based Incentive Payment System: MIPS Value Pathways

    December 1, 2022

    In November, the CMS finalized 12 MIPS Value Pathways (MVP) in the Quality Payment Program, including a rheumatology MVP. In 2023, clinicians can opt to report via traditional MIPS, the rheumatology MVP or both.

    Providers Using RISE Have Advantage with 2017 MIPS Reporting

    March 15, 2018

    Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences